Skip to menu Skip to content Skip to footer
Professor

Marc Matrana

Email: 

Overview

Availability

Professor Marc Matrana is:
Available for supervision

Works

Search Professor Marc Matrana’s works on UQ eSpace

14 works between 2016 and 2021

1 - 14 of 14 works

2021

Journal Article

A Contemporary Analysis of the 30-day Morbidity and Mortality Associated With Cytoreductive Nephrectomy

May, Danica N., Hill, Hayden, Matrana, Marc R., Lata-Arias, Kathleen and Canter, Daniel J. (2021). A Contemporary Analysis of the 30-day Morbidity and Mortality Associated With Cytoreductive Nephrectomy. Urology, 147, 186-191. doi: 10.1016/j.urology.2020.10.016

A Contemporary Analysis of the 30-day Morbidity and Mortality Associated With Cytoreductive Nephrectomy

2020

Journal Article

Precision medicine and the institutional review board: ethics and the genome

Matrana, Marc R. and Campbell, Bob (2020). Precision medicine and the institutional review board: ethics and the genome. Ochsner Journal, 20 (1), 98-103. doi: 10.31486/toj.19.0098

Precision medicine and the institutional review board: ethics and the genome

2019

Journal Article

Effect of the need for preoperative dialysis on perioperative outcomes on patients undergoing laparoscopic nephrectomy: an analysis of the National Surgical Quality Improvement Program database

May, Danica, Khaled, Dunia, Matrana, Marc R., Bardot, Stephen F., Lata-Arias, Kathleen and Canter, Daniel (2019). Effect of the need for preoperative dialysis on perioperative outcomes on patients undergoing laparoscopic nephrectomy: an analysis of the National Surgical Quality Improvement Program database. Urology, 124, 154-159. doi: 10.1016/j.urology.2018.11.010

Effect of the need for preoperative dialysis on perioperative outcomes on patients undergoing laparoscopic nephrectomy: an analysis of the National Surgical Quality Improvement Program database

2019

Journal Article

Chemotherapy Toxicity Confirms Diagnosis of Urachal Carcinoma

Maslov, Diana V., Thomas, Katharine and Matrana, Marc (2019). Chemotherapy Toxicity Confirms Diagnosis of Urachal Carcinoma. Clinical Genitourinary Cancer, 17 (5), e913-e915. doi: 10.1016/j.clgc.2019.06.017

Chemotherapy Toxicity Confirms Diagnosis of Urachal Carcinoma

2017

Journal Article

Building a phase 1 cancer research program: Lessons learned and progress made

Matrana, Marc R. and Cook, Julia (2017). Building a phase 1 cancer research program: Lessons learned and progress made. Ochsner Journal, 17 (4), 319-321. doi: 10.1043/TOJ-17-0023

Building a phase 1 cancer research program: Lessons learned and progress made

2017

Journal Article

Primary undifferentiated pleomorphic sarcoma of the penis

Yoo, Hyung Sun, Satti, Suma and Matrana, Marc (2017). Primary undifferentiated pleomorphic sarcoma of the penis. Ochsner Journal, 17 (4), 434-437. doi: 10.1043/TOJ-17-0009

Primary undifferentiated pleomorphic sarcoma of the penis

2017

Journal Article

Outcomes of patients with late-relapse metastatic renal cell carcinoma treated with targeted therapies: a single institution experience

Kucharczyk, John, Mandalapu, Kamal, Satti, Suma and Matrana, Marc R. (2017). Outcomes of patients with late-relapse metastatic renal cell carcinoma treated with targeted therapies: a single institution experience. Ochsner Journal, 17 (4), 331-334. doi: 10.1043/TOJ-17-0017

Outcomes of patients with late-relapse metastatic renal cell carcinoma treated with targeted therapies: a single institution experience

2016

Journal Article

Outcomes of patients with metastatic non-clear-cell renal cell carcinoma treated with Pazopanib

Matrana, Marc R. , Baiomy, Ali, Campbell, Matthew, Alamri, Suhail, Shetty, Aditya, Teegavarapu, Purnima, Kalra, Sarathi, Xiao, Lianchun, Atkinson, Bradley, Corn, Paul, Jonasch, Eric, Elsayes, Khaled M. and Tannir, Nizar M. (2016). Outcomes of patients with metastatic non-clear-cell renal cell carcinoma treated with Pazopanib. Clinical Genitourinary Cancer, 15 (2), e205-e208. doi: 10.1016/j.clgc.2016.07.016

Outcomes of patients with metastatic non-clear-cell renal cell carcinoma treated with Pazopanib

2016

Journal Article

Metastatic prostate cancer 35 years after sex reassignment surgery

Ellent, Elizabeth and Matrana, Marc R. (2016). Metastatic prostate cancer 35 years after sex reassignment surgery. Clinical Genitourinary Cancer, 14 (2), e207-e209. doi: 10.1016/j.clgc.2015.11.007

Metastatic prostate cancer 35 years after sex reassignment surgery

2016

Journal Article

Emerging immunotargets and immunotherapies in prostate cancer

Montironi, Rodolfo, Santoni, Matteo, Sotte, Valeria, Cheng, Liang, Lopez-Beltran, Antonio, Massari, Francesco, Matrana, Marc R., Moch, Holger, Berardi, Rossana and Scarpelli, Marina (2016). Emerging immunotargets and immunotherapies in prostate cancer. Current Drug Targets, 17 (7), 777-782. doi: 10.2174/1389450117666160217123304

Emerging immunotargets and immunotherapies in prostate cancer

2016

Journal Article

An overview of emerging immunotargets of genitourinary tumors

Montironi, Rodolfo, Santoni, Matteo, Cheng, Liang, Lopez-Beltran, Antonio, Massari, Francesco, Matrana, Marc R., Moch, Holger and Scarpelli, Marina (2016). An overview of emerging immunotargets of genitourinary tumors. Current Drug Targets, 17 (7), 750-756. doi: 10.2174/1389450117666151209144649

An overview of emerging immunotargets of genitourinary tumors

2016

Book Chapter

Renal medullary carcinoma

Pai, Sachin and Matrana, Marc R. (2016). Renal medullary carcinoma. Rare Genitourinary Tumors. (pp. 31-40) edited by Lance Pagliaro. Cham, Switzerland: Springer International Publishing. doi: 10.1007/978-3-319-30046-7_2

Renal medullary carcinoma

2016

Journal Article

Emerging immunotargets in metastatic renal cell carcinoma

Kucharczyk, John, Matrana, Marc R., Santoni, Matteo, Massari, Francesco, Scarpelli, Marina, Cheng, Liang, Lopez-Beltran, Antonio, Cascinu, Stefano, Montironi, Rodolfo and Holger, Moch (2016). Emerging immunotargets in metastatic renal cell carcinoma. Current Drug Targets, 17 (7), 771-776. doi: 10.2174/1389450117666151209115753

Emerging immunotargets in metastatic renal cell carcinoma

2016

Journal Article

Emerging immunotargets in bladder cancer

Massari, Francesco, Ciccarese, Chiara, Vau, Nuno, Santoni, Matteo, Montironi, Rodolfo, Cheng, Liang, Marques, Rita C., Scarpelli, Marina, Fonseca, Jorge, Matrana, Marc R., Holger, Moch, Cascinu, Stefano, Tortora, Giampaolo and Lopez-Beltran, Antonio (2016). Emerging immunotargets in bladder cancer. Current Drug Targets, 17 (7), 757-770. doi: 10.2174/1389450117666160201105537

Emerging immunotargets in bladder cancer

Funding

Past funding

  • 2017 - 2018
    Personalized medicine for renal cell carcinoma patients: use of patient-derived tumors for 3-D cell culture and animal models
    UQ-Ochsner Seed Fund for Collaborative Research - MABS funds
    Open grant
  • 2016
    Understanding the role of lymph node stromal microenvironment in renal cell carcinoma progression: Phase 3 - a patient-derived orthotopic xenograft model for drugs targeting RCC metastasis
    UQ-Ochsner Seed Fund for Collaborative Research - DVCR funds
    Open grant
  • 2015
    Understanding the role of lymph node stromal microenvironment in renal cell carcinoma progression: Phase 2 - identifying personalized therapeutic strategies
    UQ-Ochsner Seed Fund for Collaborative Research - DVCR funds
    Open grant

Supervision

Availability

Professor Marc Matrana is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Professor Marc Matrana's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au